Cervical cancer in the era of precision medicine: A perspective from developing countries

Cervical cancer in the era of precision medicine: A perspective from developing countries

Cervical cancer (CC) constitutes about 70%–80% of squamous cell carcinoma and 10%–15% of adenocarcinoma. In about 90% of CC cases the Human papillomavirus (HPV) infection appears to be the main culprit. Other risk factors include smoking, compromised immune system, birth control pills, starting sex...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naresh Poondla, Dhatri Madduru, Santosh Kumari Duppala, Suresh Velpula, Vandana Nunia, Simmi Kharb, Somenath Ghatak, Ashwani Kumar Mishra, Sugunakar Vuree, Md Kausar Neyaz, Prashanth Suravajhala
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Cervical cancer
Prevalence
Diagnosis
Prevention
Treatment
Clinical trials
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/56984cbfd9ee4f35990dc0ae6fa62ced
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/56984cbfd9ee4f35990dc0ae6fa62ced

Ejemplares similares